News & Events

Stanford Byers Center for Biodesign makes news with innovative health technologies and remarkable stories of industry leadership. Read about us right here.

Save the date: the Fogarty Lecture with Lisa Earnhardt

The 23rd Annual Thomas J. Fogarty Lecture will take place on Friday, October 8, from 4-5:30pm and feature Lisa Earnhardt, executive vice president of medical devices at Abbott. Watch this space for more information and registration details!




Recordings from Past Lectures

Access Recordings

Device Talks Weekly, 5/28/21 Makower Making Medtech Innovation "Bigger, Stronger"

Incoming Stanford Biodesign Director Josh Makower on finding your way to the next big innovative idea, why reimbursement needs to be solved, and a new focus for the Center on developing data-driven guidelines on policy.   

Stanford Medicine News, 5/6/21 Ingrid Ellerbe to lead Stanford Biodesign Health Technology Diversity Initiative

Education advocate Ingrid Ellerbe will be the first executive director of Diversity by Doing Healthtech (DxD), the industry-wide diversity initiative led by Stanford Biodesign and Fogarty Innovation.   

Fogarty Innovation, 5/5/21 Diversity by Doing Healthtech (DxD) Welcomes New Executive Director Ingrid Ellerbe

Ingrid Ellerbe has become the first executive director of Diversity by Doing Healthtech (DxD), the industry-wide diversity initiative led by Stanford Biodesign and Fogarty Innovation.   

Stanford Medicine News 3/23/21 Josh Makower Named New Director of Stanford Byers Center for Biodesign

Josh Makower, MD, MBA, an industry leader in health care technology and a co-founder of Stanford Biodesign, will return to become the new director on August 1.   

Daily Journal, 3/13/21 Calumeo Launches New FDA-Cleared Device that rapidly processes N95 Masks for Reuse

Calumeo, a company formed by a team of physicians, engineers, and business school students who were teammates in the Stanford Biodesign Innovation course, have launched a point-of-care device that safely and effectively processes N95 masks for reuse without the use of toxic chemicals.   

Fast Company, 3/9/21 The 10 Most Innovative Wellness Companies of 2021

Emme, a smart pill case and companion app that helps women remember to take their birth control pills, tracks cycles, and more, made #4 on the list of most innovative wellness companies. The company was co-founded by 2016-17 Biodesign Innovation Fellowship alums Amanda French and Janene Fuerch. 

Stanford Medicine Scope, 2/22/21 Real-World Evidence Improves Treatment Options for Kids

An approach to regulatory decision-making based on real-world evidence is making it easier to evaluate the safety and effectiveness of devices for pediatric patients. The UCSF-Stanford Pediatric Device Consortium, which James Wall co-directs on behalf of the Stanford Byers Center for Biodesign, is one of the first to use this approach. 

Stanford Today, 2/16/21 THree Stanford Faculty Elected to the National Academy of Engineering

Josh Makower, an adjunct professor of medicine, the lead architect of the biodesign innovation process, and the co-founder of the Stanford Biodesign Innovation Fellowship, has been elected to the 2021 class of the NAE. 

Biodesign Email Alerts

Sign-up to be notified of Biodesign news and events.

Stanford Medicine Scope, 2/16/21 Biodesign and otolaryngology team up for hearing loss and other ear, nose, and throat challenges.

A shared passion for solving important problems in care has fueled a multi-faceted collaboration between Stanford Biodesign and the Department of Otolaryngology that is generating solutions for patients and translational research opportunties for ENT faculty. 

BD News, 2/2/21 Bright Minds. Big Problems. Bold Innovation for Med Tech

Every year, trainees at Stanford Biodesign set their sights on tackling compelling unmet clinical needs—from river blindness to COVID-19 to geriatric quality-of-life issues—in hopes of positively impacting healthcare with pragmatic innovations to help countless patients around the world. Learn more about how BD supports this program to build future health tech leaders.

Fogarty Innovation Newsletter, 1/28/21 Looking Forward: Two Industry Veterans Share 2021 Predictions

If you’re looking for two medtech pioneers who have “seen it all,” Fogarty Innovation board members Tom Krummel, MD, and Casey McGlynn come to mind, given their longevity and deep roots in the industry. Recently, Fogarty Innovation had a lively discussion about how 2020 shook out, and what they predict for 2021.  

Stanford Libraries YouTube, 1/27/21 Silicon Valley Talks Mentorship

What do mentors do and how do they shape lives and careers? In this conversation, John Simpson, Paul Yock, and Kate Garrett, three distinguished health technology leaders with interlinked mentoring relationships, share their experiences and advice. 

Stanford Medicine Scope, 1/5/21 A Digital Approach to End-of-Life Planning

Important conversations about end-of-life are often skipped, leaving patients voiceless about the kind of care they want in a crisis. Two Stanford physicians in Biodesign's Building for Digital Health course developed an app that could help.

Stanford Today, 12/14/20 Stanford Students Reimagine Mental Healthcare from the Ground Up

Inspired by their time in Stanford Biodesign courses, these graduate students put the biodesign innovation process to work to tackle the biggest problems in mental healthcare: access, prescribing, and cost, and develop a data-driven solution.

Fogarty Innovation, 12/2/20 A Salute to Paul Yock and His Legacy

A fireside videochat hosted by Fogarty Innovation CEO Andrew Cleeland offered an intimate glimpse into the life and achievements of Paul Yock, MD, the founder of Stanford Biodesign and an icon in health technology innovation.  

The Lily - A Washington Post publication, 11/13/20 Most men believe their workplace empowers women. Their female counterparts don't agree.

A Stanford Biodesign survey sheds light on one reason gender bias and discrimination may persist: that men don't notice the prevalence of discrimination at the same rate as women. Biodesign academic programs director Lyn Denend comments and offers a realistic program for change.  

Harvard Business Review, 11/6/20 Small Wins Can Make a Big Impact on Gender Equality

After an internal survey at Stanford Biodesign revealed the same gender bias and male/female perception gap that we found in our industry-wide research, we adopted the small wins change model to set achievable goals and make progress towards systemic transformation.